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Introduction: Glutathione (GSH), a major redox regulator and antioxidant, is decreased in cerebrospinal fluid and prefrontal 
cortex of schizophrenia patients [1]. The genes of the key GSH-synthesizing 
enzyme, glutamate-cysteine ligase catalytic (GCLC) and modifier (GCLM) 
subunits, are associated with schizophrenia, suggesting that the deficit in 
GSH synthesis is of genetic origin [2]. GCLM knock-out (KO) mice, which 
display a 80% decrease in brain GSH levels, have abnormal brain 
morphology and function [3].In schizophrenia, a developmental redox 
dysregulation may constitute one pathological “hub” on which converge 
genetic impairments of GSH synthesis and environmental risk factors 
generating oxidative stress [3]. Here, we used GCLM KO mice to 
investigate the impact of a genetically deregulated redox system on the 
neurochemical profile of the developing brain. The neurochemical profile of 
the frontal/anterior and occipital/posterior cortex of male and female GCLM 
KO and wild-type mice was determined by in vivo 1H NMR spectroscopy on 
postnatal days 10, 20, 30, 60 and 90. 
Methods: Localised 1H NMR spectroscopy was performed on a 14.1 
T, 26 cm VNMRS spectrometer (Varian, Magnex) using a home-built 8 mm 
diameter quadrature surface coil (used both for RF excitation and signal 
reception). Mice were anaesthetized under 1 to 2% isoflurane in oxygen gas. 
Field homogeneity was adjusted by FASTMAP [4], and 1H NMR spectra 
were acquired from VOIs of 2.5 to 4 μL placed in anterior or posterior 
regions of the cortex, using SPECIAL [5,6] with TE of 2.8 ms and TR of 4 
s. Typically, spectra were acquired with 480 scans. Metabolite 
concentrations were estimated with LCModel [7], using corrections for 
water content variation during development. Data was analyzed with a 
combined statistical linear model accounting for several variables including 
cortical area, genotype and age. 
Results: The present study reports alterations of the neurochemical 
profile in the cortex of a mouse model of redox deregulation induced by 
genetic reduction of glutathione synthesis (figure 1). 1H NMR spectroscopy 
at 14.1 T allowed the in vivo quantification of a neurochemical profile 
composed of 18 metabolites [6]. The evolution of this neurochemical profile 
was generally similar in both cortical regions of WT mice, with slight 
differences that were previously reported to the society [8]. GCLM KO mice 
displayed nearly undetectable GSH levels as compared to WT mice, 
demonstrating their drastic redox deregulation. Depletion of GSH triggered 
alteration of metabolites related to its synthesis, namely increase of glycine 
and glutamate levels during development. Concentrations of glutamine and 
aspartate that are produced from glutamate were also increased in GCLM 
KO animals relative to WT. In addition, GCLM KO mice also showed 
higher levels of N-acetylaspartate that originates from the acetylation of 
aspartate. These metabolites are particularly implicated in neurotransmission 
processes and in mitochondrial oxidative metabolism. Their increase may 
indicate impaired mitochondrial metabolism with concomitant accumulation 
of lactate in the adult mice (P60 and P90).  
Conclusion: The observed metabolic alterations in the cortex of a 
mouse model of redox deregulation suggest impaired mitochondrial 
metabolism and eventually altered neurotransmission, both possibly 
triggering degeneration. 
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